Endurance Wealth Management, Inc. Biogen Inc. Transaction History

Endurance Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 18, 2019	SELL	$217.44 - $243.88 $14,133 - $15,852	-65 Closed	0 $0
Q2 2019 Jul 30, 2019	SELL	$219.29 - $241.72 $1.11 Million - $1.22 Million	-5,065 Reduced 98.73%	65 $15,000
Q4 2018 Jan 14, 2019	SELL	$278.5 - $352.75 $19,495 - $24,692	-70 Reduced 1.35%	5,130 $1.54 Million
Q3 2017 Oct 19, 2017	BUY	$281.15 - $329.69 $1.46 Million - $1.71 Million	5,200	5,200 $1.63 Million

1,050

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Endurance Wealth Management, Inc. with notifications on news.